Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

(NVLS)

(NVLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

55th STREET POST OFFICE BOX 18387 BOULDER CO 80308 USA

www.nivalis.com P: 720-600-4740

Description:

Nivalis Therapeutics, Inc. is a pharmaceutical company. The company is engaged in discovery, development and commercialization of molecule therapeutics for cystic fibrosis. Nivalis Therapeutics, Inc. is headquartered in Boulder, Colorado.

Key Statistics

Overview:

Market Capitalization, $K 36,801
Shares Outstanding, K 15,660
Annual Sales, $ 0 K
Annual Net Income, $ -31,460 K
Last Quarter Sales, $ 29,980 K
Last Quarter Net Income, $ -8,920 K
60-Month Beta 0.01
% of Insider Shareholders 3.00%
% of Institutional Shareholders 52.96%

Growth:

1-Year Return 2.13%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/07/17
Earnings Per Share ttm -2.09
EPS Growth vs. Prev Qtr 67.86%
EPS Growth vs. Prev Year 67.27%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payable Date 12/27/04
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 07/24/17

NVLS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -57.69%
Return-on-Assets % -52.88%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales 1.23
Price/Cash Flow N/A
Price/Book 0.82
Book Value/Share 3.14
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar